# Molecular Assemblies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/molecular-assemblies

- Industry: Biotechnology
- Headquarters: San Diego, US
- Website: www.molecularassemblies.com
- Total disclosed funding: $64M
- Latest round: Series B (Mar 15, 2022)
- Investors on record: 12

## About

Founded in 2013 and based in California, US, Molecular Assemblies, Inc. develops enzymatic DNA synthesis technology with applications in life sciences, industrial, information storage, nanotechnology, and DNA electronics. The company was co-founded by William Efcavitch and others. Molecular Assemblies, Inc. raised USD 25.8 million in series B funding from Casdin Capital, including Agilent Technologies Inc., Argonautic Ventures, Codexis, Inc., iSelect Fund Management, and Lyfe Capital, valuing the company at USD 104.5 million post-money. As of August 2023, Michael J. Kamdar serves as the CEO of the company.

The company offers fully enzymatic synthesis™ (FES) technology for synthetic DNA. FES functions at above 99.9% cycle efficiency, creating pure DNA regardless of length or complexity. This method eliminates weeks of purification time, allowing the company to supply experiment-ready DNA instantly. Researchers can construct donor template DNA and CRISPR libraries for various CRISPR edit types using Molecular Assemblies' technology. Next-generation sequencing applications include the development of amplicon or hybridization NGS enrichment panels as well as Unique Molecular Identifiers (UMIs) for precise sequence targeting. In addition, the organization provides gene assembly services, providing gene fragments or huge genetic structures regardless of sequence complexity.

## Funding rounds

- Series B, Mar 15, 2022, $26M — Agilent Technologies Inc., Codexis, Inc., Casdin Capital, iSelect Fund Management, LYFE Capital, Argonautic Ventures
- Series B, Sep 7, 2021, $20M — Argonautic Ventures
- Series A, Jan 4, 2021, $12M — Alexandria Venture Investments, Codexis, Inc., iSelect Fund Management, LYFE Capital, Argonautic Ventures
- Series A, Sep 27, 2019, $3.7M — Alexandria Venture Investments, Agilent Technologies Inc., iSelect Fund Management, Keshif Ventures, Argonautic Ventures
- Seed, Dec 12, 2016, $2.3M — Alexandria Venture Investments, Agilent Technologies Inc., Newport Holdings, 11.2 Capital, Keshif Ventures, Cavendish Impact Capital, Genomics Investment Syndicate

## Investors

- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Seed, Series A
- Agilent Technologies Inc. — Seed, Series A, Series B
- Newport Holdings (https://capitalatlas.ai/funds/newport-holdings) — Seed
- 11.2 Capital (https://capitalatlas.ai/funds/11-2-capital) — Seed
- Keshif Ventures (https://capitalatlas.ai/funds/keshif-ventures) — Seed, Series A
- Cavendish Impact Capital — Seed
- Genomics Investment Syndicate — Seed
- iSelect Fund Management (https://capitalatlas.ai/funds/iselect-fund-management) — Series A, Series B
- Argonautic Ventures (https://capitalatlas.ai/funds/argonautic-ventures) — Series A, Series B
- Codexis, Inc. — Series A, Series B
- LYFE Capital — Series A, Series B
- Casdin Capital (https://capitalatlas.ai/funds/casdin-capital) — Series B